|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: HELIX BIOMEDIX INC, 10QSB, 2000-08-14 |
Next: WESTMED VENTURE PARTNERS 2 LP, 10-Q, 2000-08-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
The information contained herein is derived from and qualified in its entirety
to the financial statements contained in the Company's 10-QSB for the period
ended June 30, 2000.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-END> JUN-30-2000
<CASH> 967753
<SECURITIES> 0
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 974128
<PP&E> 1984
<DEPRECIATION> (369)
<TOTAL-ASSETS> 1479579
<CURRENT-LIABILITIES> 197165
<BONDS> 0
0
0
<COMMON> 5596873
<OTHER-SE> (4640767)
<TOTAL-LIABILITY-AND-EQUITY> 1479579
<SALES> 0
<TOTAL-REVENUES> 0
<CGS> 0
<TOTAL-COSTS> 0
<OTHER-EXPENSES> 292517
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 4199
<INCOME-PRETAX> (296176)
<INCOME-TAX> 0
<INCOME-CONTINUING> (296176)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (296176)
<EPS-BASIC> (.06)
<EPS-DILUTED> (.06)
</TABLE>
|
|